NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma

Glioblastoma (GBM) is the most common primary intracranial malignancy. GBM still exhibits high recurrence and mortality rates even following combined treatment with surgery, radiotherapy and chemotherapy, Therefore, the identification of novel therapeutic targets is urgent. Previous research has sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qiuyun, Han, Na, Shi, Lei, Yang, Li, Zhang, Xiaoxi, Zhou, Yangmei, Yu, Shiying, Zhang, Mengxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667917/
https://www.ncbi.nlm.nih.gov/pubmed/31322259
http://dx.doi.org/10.3892/or.2019.7227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667917/
https://www.ncbi.nlm.nih.gov/pubmed/31322259
http://dx.doi.org/10.3892/or.2019.7227

Ejemplares similares